Scratch Migration Assay and Dorsal Skinfold Chamber for In Vitro and In Vivo Analysis of Wound Healing

Summary

Here, we present a protocol for an in vitro scratch assay using primary fibroblasts and for an in vivo skin wound healing assay in mice. Both assays are straightforward methods to assess in vitro and in vivo wound healing.

Abstract

Impaired cutaneous wound healing is a major concern for patients suffering from diabetes and for elderly people, and there is a need for an effective treatment. Appropriate in vitro and in vivo approaches are essential for the identification of new target molecules for drug treatments to improve the skin wound healing process. We identified the β3 subunit of voltage-gated calcium channels (Cavβ3) as a potential target molecule to influence the wound healing in two independent assays, i.e., the in vitro scratch migration assay and the in vivo dorsal skinfold chamber model. Primary mouse embryonic fibroblasts (MEFs) acutely isolated from wild-type (WT) and Cavβ3-deficient mice (Cavβ3 KO) or fibroblasts acutely isolated from WT mice treated with siRNA to down-regulate the expression of the Cacnb3 gene, encoding Cavβ3, were used. A scratch was applied on a confluent cell monolayer and the gap closure was followed by taking microscopic images at defined time points until complete repopulation of the gap by the migrating cells. These images were analyzed, and the cell migration rate was determined for each condition. In an in vivo assay, we implanted a dorsal skinfold chamber on WT and Cavβ3 KO mice, applied a defined circular wound of 2 mm diameter, covered the wound with a glass coverslip to protect it from infections and desiccation, and monitored the macroscopic wound closure over time. Wound closure was significantly faster in Cacnb3-gene-deficient mice. Because the results of the in vivo and the in vitro assays correlate well, the in vitro assay may be useful for the high-throughput screening before validating the in vitro hits by the in vivo wound healing model. What we have shown here for wild-type and Cavβ3-deficient mice or cells might also be applicable for specific molecules other than Cavβ3.

Introduction

Skin wound healing starts immediately after the skin injury in order to restore the skin's integrity and to protect the organism from infections. The wound healing process goes through four overlapping phases; coagulation, inflammation, new tissue formation, and tissue remodeling¹. Cell migration is crucial during these phases. Inflammatory cells, immune cells, keratinocytes, endothelial cells, and fibroblasts are activated at different time points and invade the wound area². Methods to investigate wound healing in vitro and in vivo are of great interest not only to understand the underlying mechanisms but also to test new drugs and to develop new strategies aiming to ameliorate and accelerate skin wound healing.

To monitor and analyze cell migration, the scratch migration assay can be used. It is often referred to as in vitro wound healing assay. This method requires a cell culture facility³. It is a simple procedure, there is no need of high-end equipment and the assay can be performed in most cell biology laboratories. In this assay, a cell-free area is created by the mechanical disruption of a confluent cell monolayer, preferably epithelial- or endothelial-like cells or fibroblasts. Cells on the edge of the scratch will migrate in order to repopulate the created gap. Quantification of the decreasing cell-free area over time resembles the migration rate and indicates the time, which the cells need to close the gap. For this purpose, investigators can use either acutely isolated cells from WT mice or mice lacking a gene of interest⁴, or immortalized cells available from reliable cell repositories. The scratch assay allows studying the influence of pharmacologically active compounds or the effect of transfected cDNAs or siRNAs on cell migration.

In vivo, wound healing is a complex physiological process, requiring different cell types including keratinocytes, inflammatory cells, fibroblasts, immune cells and endothelial cells in order to restore the skin’s physical integrity as fast as possible¹. Different methods to study in vivo wound healing have been developed and used in the past^5,6,7,8. The dorsal skinfold chamber described in this article was previously used for wound healing assays⁹. It is used as a modified dorsal skinfold chamber preparation for mice. The modified skinfold chamber model has several advantages. 1) It minimizes skin contraction, which prevents observing the wound healing process and might influence wound repair in mice. 2) This chamber makes use of covering the wound with a glass coverslip, reducing tissue infections and desiccation, which could delay the healing process. 3) Blood flow and vascularization can be directly monitored. 4) It allows repetitive topical application of pharmacologically active compounds and reagents in order to treat the wound and accelerate healing^9,10.

We identified the β3 subunit of high voltage-gated calcium channels (Cavβ3) as a potential target molecule to influence skin wound healing using two independent protocols, i.e., the in vitro scratch migration assay and the in vivo dorsal skinfold chamber model. For the in vitro assay, we used primary fibroblasts, these cells do express the Cacnb3 gene encoding the Cavβ3 protein but lack depolarization-induced Ca²⁺ influx or voltage-dependent Ca²⁺ currents. We described a novel function of Cavβ3 in these fibroblasts: Cavβ3 binds to the inositol 1,4,5-trisphosphate receptor (IP3R) and constraints calcium release from the endoplasmic reticulum. Deletion of the Cacnb3 gene in mice leads to increased sensitivity of the IP3R for IP3, enhanced cell migration and increased skin wound repair⁴.

Protocol

All experimental procedures were approved and performed in accordance with the ethics regulations and the animal welfare committees of Saarland and Saarland University.

1 Primary cell culture and siRNA transfection

NOTE: In the described method, primary fibroblasts are used. These cells play a crucial role in wound healing and tissue remodeling¹¹. In this experiment, the Cacnb3 gene, encoding the Cavβ3 subunit of high voltage-gated calcium channels¹² was down-regulated, thereby showing its role in cell migration in vitro and skin wound repair in vivo⁴.

1. Preparation of siRNA: Before reconstituting the siRNAs, briefly centrifuge the tubes to ensure that the content is at the bottom. Reconstitute the siRNAs in 100 µL RNase-free buffer (100 mM potassium acetate, 30 mM HEPES, pH 7.5) provided by the manufacturer at a concentration of 20 µM. This is a stock solution of siRNAs.
2. Aliquot this stock solution at 10 µL per tube (20 µM concentration) and store at -20 °C until use.
3. Using an ultrafine permanent marker, mark a 6-well plate with a horizontal line at the bottom of each well in order to be able to always identify the same scratch region of interest and to follow its closure.
   NOTE: 6-well culture plates were used in this assay because they are large enough, to provide enough space and flexibility to apply a consistent, reproducible and vertical scratch using a 200 µL pipette tip across the cell monolayer. If a limited number of cells are available, an alternative and probably the cost-efficient way would be to use 12- or 24-well culture plates.
4. Plate primary fibroblasts, isolated from the wild-type and β3-deficient mice⁴, in a 6-well plate at a density of 5 x 10⁵ cells/well in the presence of 2 mL Dulbecco’s modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FCS).
   NOTE: 5 x 10⁵ cells per well has been established for 6-well culture plate and for primary mouse fibroblasts. Tests may be needed if using 12- or 24-well cell culture plates or other cell types, which could be different in size. Cells should be handled in a sterile environment such as biological safety cabinets class II.
5. Label the 6-well plate with the cell type, genotype, and the date.
6. Move the 6-well plate into the cell culture incubator and maintain cells at 37 °C and 5% CO₂ for 24 h.
7. The next day, take the plate out of the incubator, aspirate the cell culture medium out of the well, discard it and replace it with 2.25 mL fresh culture medium by adding it carefully against the wall of the well.
8. In order to transfect fibroblasts with siRNAs, use a lipid-based transfection reagent as recommended by the manufacturer.
9. For each transfection, label two microcentrifuge tubes. In the first one, add 9 µL of the transfection reagent and dilute it with 150 µL reduced serum medium. In the second tube, add 1.5 µL siRNA (Cacnb3 siRNA-1, Cacnb3 siRNA-2 or scrambled siRNA as a negative control) and dilute it with 150 µL reduced serum medium.
10. Add the diluted siRNA into the tube containing diluted transfection reagent and vortex for 2 s. Incubate the mixture for 5 min at 21 °C.
11. Label wells with either Cacnb3 siRNA-1, Cacnb3 siRNA-2 or scrambled siRNA. Add 250 µL of the siRNA-transfection reagent mixture dropwise to the cells.
12. Place the 6-well culture plate back into the incubator and keep cells at 37 °C and 5% CO₂ for 72 h.
13. In order to check the efficiency of Cacnb3 gene silencing, collect transfected cells and perform immunoblot analysis as described previously⁴.

2. In vitro wound healing assay (scratch migration assay)

1. Take the cell culture plate out of the incubator and examine the cells under the microscope using the 10x objective. Start with the scratch assay only when they have reached 100% confluency.
   NOTE: For the accuracy and reproducibility, 100% confluency is a mandatory factor for starting the scratch migration assay. Therefore, it is important to seed the same number of cells into the culture wells, to examine each well for confluency and to apply the scratch at the same time point (day 0 confluency). Waiting for longer after the cells reach 100% confluency can evoke different responses.
2. Once the cell reaches 100% confluency, aspirate the culture medium out of the well and discard it.
3. Use a pipette tip (200 µL) to manually create a scratch vertical to the horizontal line marked at the bottom of the well, across the confluent cell monolayer in the middle of the well.
4. Rinse each well twice with 2 mL phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH₂PO₄, 8.1 mM Na₂HPO₄, pH 7.4) to remove the released factors from damaged cells, loose cells, and debris from the scratched area. Add 2 mL of PBS carefully against the wall of the well to avoid detaching cells from the cell culture well.
5. Add 2 mL of cell culture medium containing either 10% serum or 1% serum carefully to each well.
   NOTE: It is recommended to perform the scratch assay under 10% serum and under 1% serum to confirm that the observed effect is caused by the cell proliferation and migration or by cell migration only.
6. Move the plate to the microscope stage and capture bright field images of the cell-free area (two areas per well) immediately after scratching (t=0h) at a 10x magnification using a light microscope. To image always the same region of the scratch, use the horizontal line, which was prepared in step (1.3), and take one image above this line and one image below this line. Save images as TIFF or JPEG.
7. Because the microscope stage does not maintain the cell growth condition, move the plate back to the cell culture incubator and keep the cells at 37 °C and 5% CO₂.
8. After 6, 10 and 30 h, move the plate to the microscope stage again and capture images the same way as described in step 2.6.
   NOTE: These time points have been established for the described procedure and for primary fibroblasts. During the first pilot experiment, more time points were tested to see how fast fibroblasts repopulate the gap. Although 0, 6, 10 and 30 h are reasonable starting time points, the investigators should optimize and establish the appropriate time points for each application and for each cell type. The more accurate alternative, if available, would be to use time-lapse microscopy.
9. Using ImageJ¹³, quantify the initial cell-free area (100%) and the remaining area after 6, 10 and 30 h (Figure 1). The percentage of scratch area repopulated by migrating cells is then calculated relative to the initial scratch area.

3. Analysis of the scratch area

1. Open ImageJ software¹³.
2. Upload the first image as JPEG (e.g., 24-bit RGB images 1360x1024) by dropping the image into the ImageJ menu bar.
3. Select the Freehand selections button and mark the cell-free area
4. Click on Analyze and select Measure. A window with the results will appear containing the area value.
5. Transfer this value into an analysis spreadsheet.
6. Repeat steps 3.2-3.5 for each image from time point 0 h and then start again for the next time points 6, 10 and 30 h.
7. Calculate the percentage of scratch area repopulated by migrating cells after 6, 10 and 30 h for each scratch using the following equation:
   
   a = cell free area of the initial scratch, b = cell free area after 6 h
8. Calculate the mean and the standard error of the mean (S.E.M.) for the percentage of scratch area repopulated by migrating cells after 6 h. Show data as a column bar graph or a scatter plot.

4. In vivo skin wound healing assay

NOTE: C57BL/6 wild-type males (8-12 weeks old with 22-26 g body weight) and Cavβ3-deficient mice as a control are used for this study.

1. One day before starting the experiment, autoclave all the surgical instruments, screws, nuts and titanium frames to be used for the skinfold chamber preparation.
   NOTE: The titanium frame is composed of two symmetrical complementary halves and it has a circular observation window where the wound will be applied and followed by microscopy (see Figure 2a).
2. Anesthetize a wild-type or β3-deficient mouse (22-26 g body weight) by intraperitoneal (i.p.) injection of 0.1 mL saline/10 g body weight containing a mixture of ketamine (75 mg/kg body weight) and xylazine (25 mg/kg body weight). Check the depth of anesthesia by the lack of response to a toe pinch.
   NOTE: This injection gives around 30 min surgical anesthesia and the depth of anesthesia must be controlled through the surgical procedure, by checking the reflexes of the mouse.
3. To avoid dryness or damage of the eyes, apply ophthalmic ointment to both eyes and repeat the application if necessary.
4. Carefully shave the mouse dorsum, using an electric shaver followed by the application of a depilation cream to the shaved area to remove any remaining hair. Take care not to injure the mouse skin. Leave the depilation cream for around 10 min to completely remove all hair.
5. Prepare the titanium chamber by taking one part of the symmetrical titanium chamber frame and fix the connecting screws with nuts on one side. These nuts will serve as a spacer to keep 400-500 µm between the two symmetrical parts of the chamber to avoid compression of blood vessels in the skin.
6. Remove the cream from the back of the mouse and clean the hair-free region with warm (35-37 °C) tap water.
7. Make sure that the place to perform surgery is clean, warm (37 °C) and humidified.
8. Disinfect the hair-free area of the mouse with skin disinfectant. Take a fold of the back skin of the mouse in front of a light source and position the middle line of the double layer of the skin where the titanium chamber will be implanted. After that, fix the skinfold with a polypropylene suture cranially and caudally and tighten the other side of the suture on a metal rack to lift the mouse folded skin. Adjust the height of the rack to allow the mouse to sit comfortably.
9. Implant the titanium chamber into the fold of the back skin of the mouse in a way to sandwich the folded dorsal skin layer between the two symmetrical halves of the titanium frame. Attach the first half of the titanium frame by polypropylene sutures on its superior edge to the back of the dorsal skinfold.
   NOTE: On the titanium frame, there are 8 holes on the superior edge (Figure 2a) and the folded skin should be well fixed by polypropylene sutures on each of the eight holes.
10. Before moving to the next step, check the reflexes of the mouse to make sure that the depth of anesthesia is maintained.
11. At the base of the skinfold, pass the two connecting screws, attached to the first half of the titanium chamber, to penetrate the skinfold from back to the front side. Make small incisions on the skin (using fine scissors) to help smooth penetration of the connecting screws.
12. Detach the mouse from the rack and place it on a lateral position. Put the second complementary half of the titanium chamber on top of the 3 connecting screws (see Figure 2a) and apply slight pressure with fingers in order to pass these screws through the second half of the titanium frame. Then, fix both symmetrical parts with stainless steel nuts.
13. Pay careful attention to the tightness of the screws at this step, since it might detach, if it is too loose. In contrast, if it is too tight, it will squeeze the skinfold, reduce blood flow and can lead to tissue impairment and necrosis.
    NOTE: Nuts prepared in step 4.5 serve as a spacer to keep a distance of 400-500 µm between the two symmetrical halves of the titanium chamber. The nuts should be tightened until a slight resistance is felt.
14. Cut the remaining part of the screws using pliers.
    NOTE: It is necessary at this step to use laboratory safety glasses for eye protection in case the screw comes off the wrong way.
15. Mark the wound area by a standardized biopsy punch (2 mm in diameter), in the center of the skin within the observation window (see Figure 2a) of the skinfold chamber in order to ensure reproducible wound sizes.
16. By using fine forceps and scissors, create a circular wound within the marked area by removing the complete skin with epidermis and dermis. The final wound area will be around 3.5-4.5 mm², see Figure 2b. Clean the wound with 0.5 mL sterile saline (0.9 % NaCl, 37 °C).
17. Cover the wound with a glass coverslip and fix this glass coverslip with a snap ring using the snap ring plier on the titanium chamber.
18. Immediately after finishing the surgical procedure, place the mouse on the imaging stage of a stereomicroscope equipped with a camera and take images (day 0) under illumination. Use the 40X magnification and save the images for future off-line analysis.
    NOTE: The investigator should examine the images immediately after capture to ensure that quality is sufficient for future off-line analyses. The preparation of the skinfold chamber and performance of the skin wound takes around 30 minutes.
19. Keep the mouse at a warm place during recovery from anesthesia for at least 2 h. Thereafter, transfer mice in individual cages back to the animal facility (12 h light/dark cycle) and make sure that mice have access to food and water.
20. Three days post-wounding place the mouse in a mouse-restrainer and fix the restrainer on top of the imaging stage.
21. Place the stage under a stereomicroscope equipped with a camera. Take images under illumination with 40x magnification, record all pictures and save them for future off-line analyses
22. Repeat steps 4.20 and 4.21 again at day 6, 10 and day 14 post-wounding.
23. Use the wound images, for off-line analysis in ImageJ¹³. The wound area at day 0 is considered as 100 % and the wound closure over time is plotted relative to the initial wound area. Representative results are shown in Figure 2c,d.
24. Calculate the percentage (%) of the wound area at each time point using the following equation:
    
    x: time point (day 0, 3, 10 or 14), a: wound area at day 0, b: wound area at time point x

Representative Results

The scratch assay was performed on a confluent cell monolayer of wild-type and β3-deficient MEFs (Figure 1c). After performing the "scratch" using a 200 μL pipette tip, cells from both genotypes migrate into the scratch area and close the gap. Images were taken after 6, 10 and 30 h (Figure 1a). Cell migration was quantified as the percentage (%) of scratch area repopulated by migrating cells 6 hours after performing the scratch. Migrating Cavβ3-deficient MEFs closed the scratch area significantly earlier than MEFs from wild-type mice (Figure 1a,b). To exclude any effect of cell proliferation, the scratch migration assay was performed in the presence of either 10% or 1% FCS. At 10% FCS both processes are present, the cell proliferation and migration, whereas at 1% FCS cell proliferation is minimized. Fibroblasts in 10% (Figure 1b, left) or 1% FCS (Figure 1b, right) showed a similar migration pattern, ruling out the possibility of cell proliferation contribution to the Cavβ3 observed phenotype. Cavβ3-deficient MEFs closed the gap significantly earlier than wild-type MEFs under both conditions. To confirm the Cavβ3-dependent effect observed in β3-deficient fibroblasts, wild-type fibroblasts were transfected with siRNA to down-regulate the Cavβ3 protein (Figure 1e). As a control for the down-regulation, immunoblots were performed to confirm the efficiency of the siRNA treatment. Two independent Cacnb3 specific siRNAs (siRNA1 and siRNA2), and a scrambled siRNA (as a control) were used. Fibroblasts treated with the Cacnb3-specific siRNAs behave like β3-deficient fibroblasts (Figure 1d), i.e., the migration is increased in the absence of Cavβ3 protein (Figure 1e).

In vivo, the dorsal skinfold chamber was implanted (Figure 2a,b) and a defined circular wound of 2 mm diameter was generated on the shaved back (Figure 2b) of the wild-type and Cavβ3-deficient mice (8 animals per genotype, 8-12 weeks old and 22-26 g weight). The wound was performed by removing the complete skin with epidermis and dermis. To compare skin wound healing between both genotypes, the wound area in the skin fold chamber was photographed directly after wounding (day 0) and then pictures were taken 3, 6, 10, and 14 days post wounding (Figure 2c). The sizes of the wounds were measured on these digital images and the wound area at a given day was expressed as the percentage (%) of the initial wound area (Figure 2d). Wound closure is increased in β3-deficient mice compared to wild-type controls. In contrast to the wild-type, the wound in β3-deficient mice was almost completely closed already after 10 days. At day 14 post-wounding, the wounds were completely closed in both genotypes (Figure 2c,d).

Figure 1: In vitro scratch migration assay. (a) Representative images of cultures from wild-type (WT, left) and Cavβ3 KO (β3 KO, right) primary mouse embryonic fibroblasts (MEFs) immediately, 6, 10 and 30 h after performing a scratch. Images were converted into 8-bit gray scale, and the contrast, as well as brightness, were adapted to maximally visualize the cell free area. Analysis of the cell free area (% of scratch area repopulated by migrating cells) was performed on the original 24-bit RGB images. (b) Bar graphs showing percentages (%) of scratch area repopulated by migrating cells after 6 hours either in the presence of high (10 %, left) or low (1%, right) fetal bovine serum (FCS) in wild-type (black) and Cavβ3 KO (red) experiments (c) Immunoblot: Protein extracts from wild-type brain (50 μg per lane) and fibroblasts (MEFs, 100 μg per lane) using a Cavβ3 specific antibody. The β3 protein (55 kDa) is present in wild-type brain (used as a control), and fibroblasts, but is absent in protein extracts of Cavβ3-deficient brain and fibroblasts prepared from Cavβ3-deficient mice. (d) Summary of the percentage of scratch area repopulated by migrating cells after 6 hours in wild-type cells treated with either scrambled siRNA (control, black) or two independent Cacnb3 siRNAs (siRNA1 and siRNA2, red open bars). (e) The corresponding immunoblot from the experiment in (d). Data are shown as mean ± SEM, p values were calculated using unpaired two-tailed Student’s t-test. Panels a and b have been modified from [Belkacemi et al., 2018]⁴. Please click here to view a larger version of this figure.

Figure 2: In vivo skin wound healing in mice. (a) Titanium frame interior side view showing one half of the titanium chamber and front side view showing the assembled titanium chamber with two symmetrical halves attached with screws and nuts. (b) Mouse after shaving the dorsal skin and mounting the dorsal skinfold chamber composed of two symmetric titanium frames (the weight of the titanium frame is around 2 g) and applying a circular wound (2 mm diameter). (c) Images of the wound directly after wounding (day 0) and 3, 6, 10, and 14 days post-wounding. The continuous process of wound closure, with complete epithelialization, is shown over 14 days in wild-type (WT, top) and Cavβ3 KO (β3 KO, bottom) mice. (d) At the time points indicated, the wound area was determined using a computer-assisted image analysis program and plotted as a percentage of the wound area immediately after injury at day 0 (mean ± SEM of n = 8, β3 KO mice and the corresponding wild-type control mice). P values were calculated using two-way ANOVA and Bonferroni’s multiple comparisons test. Panels c and d have been modified from [Belkacemi et al., 2018]⁴. Please click here to view a larger version of this figure.

Discussion

In this manuscript, we describe an in vitro and in vivo wound healing assay and correlate the results obtained. For the in vitro assay, we used primary mouse fibroblasts^4,14,15 which play an important role in wound healing and tissue remodeling¹¹. Other adherent cell types growing as monolayers (e.g., epithelial cells, endothelial cells, keratinocytes) can be used as well. Plating the same number of viable and healthy cells and applying the scratch at the same degree of confluency is of paramount importance in order to obtain accurate and reproducible results. It is highly recommended to perform biological and technical replicates. In the present method, 6-well plates were used, but 12- or 24-well plates can be also used especially when cells are available only at limited numbers. In the case of siRNA treatment, immunoblot analysis after each set of experiments is mandatory to make sure that the target protein is efficiently down-regulated. Transfection reagent and time window should be tested and selected for each cell type before starting with the migration assay. In the case of fibroblasts and the Cacnb3 gene, it took 3 to 4 days to reach the desired level of down-regulation. In contrast, the scratch migration assay needs shorter times (6 h to 24 h). To avoid high variability in the scratch size, it is mandatory that the same investigator applies the scratch for each set of experiments, that equal pressure is administered by the pipette tip and to keep the wound as much as possible vertical to the marked line at the bottom of the plate across the cell monolayer. Application of a mechanical scratch across the cell monolayer leads to the release of different cellular factors (e.g., ATP) from damaged cells into the extracellular space. These factors would induce paracrine signaling including Ca²⁺-signaling in the neighboring cells, which in turn would influence cellular responses¹⁶. To avoid these effects, culture inserts can be used for plating cells and after removal of these inserts a cell-free gap is created without damaging the neighboring cells¹⁷. For high-throughput screening, the investigators might consider using instruments available on the market to create reproducible and consistent scratches in 96-well plates. To follow cell migration kinetics continuously over time, users can also consider using high-end commercial systems for automatic image capture. However, automated systems for scratch application and image capture are not always available because of high costs. A more accessible and cost-effective solution for time-lapse imaging would be for example using the system (ATLIS: an affordable time-lapse imaging and incubation system) described by Hernandez Vera and colleagues¹⁸.

In the absence of any cell proliferation inhibitors, repopulation of the gap in the scratch migration assay is a combination of cell migration and cell proliferation. To monitor only cell migration, cell proliferation can be suppressed for example by treatment with either Actinomycin C¹⁹ or Mitomycin C²⁰. Adequate concentrations of these compounds must be carefully determined and tested to avoid the toxic effects of these compounds, which might affect the viability of the cells and their ability to migrate. As described in the present article, serum starvation or the reduction of the serum concentration in the culture medium is another way to reduce the effects of cell proliferation. Serum starvation is used in several other cell-based assays. It can induce a high number of cellular responses, which might interfere with the obtained results and interpretations²¹. Serum starvation must be carefully applied and its effect on the cell viability should be assessed before starting the experiment. In the present article, migration of primary fibroblasts in the presence of either 10% or 1% serum is shown (see Figure 1b). Migration rate, as expected, is slower at low concentrations of serum. However, β3-deficient fibroblasts migrate faster than wild-type cells at both conditions; low and high serum concentration.

The skin wound healing assay using the dorsal skinfold chamber is a relatively straightforward procedure to investigate skin wound closure over time in vivo. The implantation of the titanium dorsal skinfold chamber was described for the first time in rats²². Sorg et al. used this technique in SKH1-hr hairless mice to follow wound healing and formation of new blood vessels⁹. The skinfold chamber model described in this article has many advantages over the classical wound healing assays performed on the dorsal skin, on the ear²³ or hind limb⁷ of mice. Covering the wound area with a glass coverslip prevents infections and tissue trauma and limits desiccation of the wound. The observation chamber covered with the glass coverslip can be opened at any time during the healing process, allowing topical application of different pharmacologically active compounds (e.g., siRNA for Cavβ3 as solutions or ointments) and the chamber can be closed again. Murine skin wounds healing process is composed of both contraction and epithelialization²⁴. Using the dorsal skinfold chamber in mice minimizes skin contraction and gives the opportunity to study mainly the epithelialization process. It provides also a clear window to observe and monitor the wound closure process. One disadvantage of the titanium chamber is that the mouse has to carry the titanium chamber, which has a weight of around 2 g (7.7% of the weight of a 26 g mouse), for 14 days. This might cause some discomfort for the mouse, although it seems that mice tolerate well this chamber and they are comfortable and can easily reach food and water. The skin wound healing model presented in this article can study only one wound per mouse. Other published methods^25,26 suggest applying two wounds per mouse which would reduce the number of animals needed for a study. It is of great importance to create a circular wound of similar size for all mice to get objective information as well as reliable and reproducible results. To take images of the wounds over time, mice were fixed on a mouse restrainer, placed on a stage, and the skinfold chamber is positioned under a stereomicroscope. Using the restrainer helps in avoiding anesthesia and minimizing stress for the mice. Mice can be sacrificed and tissues from the wounded area can be explanted and collected at different stages of the healing process (either after complete healing or at earlier time points) for histological analysis, RNA collection or protein biochemistry.

In summary, we have shown two techniques, an in vitro scratch assay using primary fibroblasts and an in vivo skin wound healing assay in mice. In both assays, wound healing/gap closure is increased in the absence of the Cavβ3 subunit of voltage-gated calcium channels. As with wild-type and Cavβ3-deficient mice or cells, both assays might well correlate in the absence or presence of other specific molecules.

Materials

Name	Company	Catalog Number	Comments
0.9 % NaCl
1 ml syringes	BD Plastipak	303172
6 well plate	Corning	3516
Biopsy punch	Kai Industries	48201	2 mm
Cacnb3 Mouse siRNA Oligo Duplex (Locus ID 12297)	Origene	SR415626
Depilation cream			any depilation cream
Dexpanthenol 5% (BEPANTHEN)	Bayer	3400935940179.00	(BEPANTHEN)
Dihydroxylidinothiazine hydrochloride (Xylazine)	Bayer Health Care		Rompun 2%
Dulbecco's Modified Eagle Medium (DMEM)	Gibco by life technologies	41966-029
Fetal bovine serum	Gibco by life technologies	10270-106
Hexagon full nut
Ketamine hydrochloride	Zoetis		KETASET
Light microscope	Keyence, Osaka, Japan	BZ-8000	Similar microscopes might be used
Lipofectamine RNAiMAX Transfection Reagent	Thermo Fisher Scientific	13778075
Micro-forceps
Micro-Scissors
Mouse restrainer	Home-made
Normal scissors
Objective	Nikon	plan apo 10x/0.45
Opti-MEM	Gibco by life technologies	51985-026
Polypropylene sutures
Screwdriver
Skin disinfectant (octeniderm)	Schülke & Mayr GmbH	118212
Slotted cheese head screw
Snap ring
Snap ring plier
Surgical microscope with camera	Leica	Leica M651
Titanium frames for the skinfold chamber	IROLA	160001	Halteblech M
Wire piler